Quantcast

Latest Novartis Group Stories

2011-11-18 00:20:01

Tokyo, Nov 18, 2011 - (JCN Newswire) - Eisai Co. Ltd announced today that it has entered into a Japan co-promotion agreement with Novartis Pharma K.K. for three Novartis Pharma therapies for chronic obstructive pulmonary disease (COPD). These include Onbrez Inhalation Capsules 150 mcg (indacaterol maleate), which were launched in Japan on September 20, 2011, and, if approved, the investigational drugs NVA237 (glycopyrronium bromide) and QVA149 (fixed-dose combination of indacaterol maleate...

2011-09-24 07:00:00

Novartis donates 20,000 EURO to support the Cystic Fibrosis Worldwide Education program. In 2011 CFW will partner with thier member, CF Saudi Arabia to bring the first of its kind CF conference to the Middle East. (PRWEB) September 24, 2011 Novartis, a healthcare solutions company headquartered in Switzerland, has donated 20,000 EURO to Cystic Fibrosis Worldwide (CFW) education programs headed by Dr. Harry Heijerman. The Cystic Fibrosis Worldwide education team is comprised of seven top...

2011-07-01 15:59:00

EAST HANOVER, N.J., July 1, 2011 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder) 75 mcg for the long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Arcapta is not indicated for acute deteriorations of COPD or to treat asthma. To view the...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related